<DOC>
	<DOCNO>NCT01271556</DOCNO>
	<brief_summary>The cardiovascular component associate COPD play major role prognosis disease , responsible 25 % death . Experimental initial clinical data suggest beta-adrenergic agonist accelerate clearance excess fluid alveolar airspace , potential positive effect cardiogenic pulmonary edema . The aim study investigate effect long-acting beta-2 agonist , salmeterol , alveolar fluid clearance COPD patient evaluate diffusive mechanical lung property . Our experimental model test alveolar fluid clearance rapid saline intravenous infusion . Ten COPD 10 healthy subject treat salmeterol placebo 4 hour begin study evaluate , four non consecutive day , saline infusion similar period without infusion . Both COPD healthy subject rapid saline infusion , placebo salmeterol premedication , lead significant decrease DLCO FEV1 . Nonetheless , salmeterol pretreatment lead significant reduction impairment gas exchange due saline infusion ( -64 % DLCO reduction comparison placebo ) , whilst affect change FEV1 . In control setting , infusion , find significant change DLCO mechanical property lung . In conclusion , COPD patient salmeterol appear provide protective effect acute alveolar fluid clereance challenge secondary lung fluid overload provide intriguing mechanistic explanation benefit observe large trial .</brief_summary>
	<brief_title>Effect Salmeterol Fluid Clearance From Alveolar-Capillary Membrane COPD Patients</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<mesh_term>Bronchodilator Agents</mesh_term>
	<criteria>COPD diagnosis ( consistent diagnostic standard European Respiratory Society , ERS , management COPD ) stable condition â‰¥4 week prebronchodilator force expiratory volume one second ( FEV1 ) &lt; 60 % predict value know allergy study medication longterm oxygen therapy history asthma , allergic rhinitis , atopy , total blood eosinophil count great 400/mm3 chronic heart failure , untreated arterial hypertension , myocardial infarction within last 6 month , diabetes mellitus increase serum potassium level .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>COPD</keyword>
	<keyword>LABA</keyword>
	<keyword>salmeterol</keyword>
</DOC>